{"database": "press", "table": "releases", "rows": [["https://schweikert.house.gov/2021/11/17/pandemic-cessation-act/", "Congressman David Schweikert Introduces Legislation To End The Public Health Emergency Declaration Upon FDA Therapeutic Drug Approvals", "2021-11-17", "2021", "2021-11", "Republican", "House", "AZ", "David Schweikert", "S001183", "schweikert.house.gov", "schweikert", "https://schweikert.house.gov/category/congress_press_release/", "scraper", "Washington, D.C \u2013 Today, Congressman David Schweikert (AZ-06) introduced The Pandemic Cessation Act, legislation that provides closure to nearly two years of fighting the COVID-19 virus.\n\n\u201cWe are on the verge of adding multiple medical breakthroughs to our COVID-19 toolbox to defeat this pandemic once and for all. The FDA is scheduled to review the final approval of antiviral drugs that I believe should mark the end of the Public Health Emergency Declaration. The restrictions that have tied the country down for nearly two years must come to a close, and my Pandemic Cessation Act will do exactly that. It\u2019s time to clearly mark the return to normal life,\u201d said Rep. Schweikert.\n\nBackground:\n\nThe Pandemic Cessation Act would consider the current, and any renewal of, the Public Health Emergency (PHE) terminated upon the Food and Drug Administration\u2019s approval or emergency use authorization of a new drug indicated to treat COVID-19.", 1, "2026-03-30T01:40:41Z", "2026-04-06T20:30:49Z"]], "columns": ["url", "title", "date", "year", "month", "party", "chamber", "state", "member_name", "bioguide_id", "domain", "scraper", "source", "date_source", "text", "has_text", "collected_at", "updated_at"], "primary_keys": ["url"], "primary_key_values": ["https://schweikert.house.gov/2021/11/17/pandemic-cessation-act/"], "units": {}, "query_ms": 0.7298709824681282, "source": "dwillis/congress-press", "source_url": "https://github.com/dwillis/congress-press", "license": "MIT", "license_url": "https://github.com/dwillis/congress-press/blob/main/LICENSE"}